In reference to Fu et al. (neuro-Oncology 2008:10139-152).
Roesler
Rafael
R
Schröder
Nadja
N
Schwartsmann
Gilberto
G
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D006801:Humans; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D011719:Pyrazines / Q000627:therapeutic use*; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism
D000970:Antineoplastic Agents; D011719:Pyrazines; D016194:Receptors, N-Methyl-D-Aspartate; C017953:tetramethylpyrazine